Blue Fin Capital, Inc. Eli Lilly & CO Transaction History

Blue Fin Capital, Inc.

$517 Million
Q3 2024

A detailed history of Blue Fin Capital, Inc. transactions in Eli Lilly & CO stock. As of the latest transaction made, Blue Fin Capital, Inc. holds 11,071 shares of LLY stock, worth $8.5 Million. This represents 1.9% of its overall portfolio holdings.

Number of Shares

11,071

Previous 10,850 2.04%

Holding current value

$8.5 Million

Previous $9.82 Million 0.15%

% of portfolio

1.9%

Previous 1.99%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 05, 2024	BUY	$772.14 - $960.02 $170,642 - $212,164	221 Added 2.04%	11,071 $9.81 Million
Q2 2024 Jul 30, 2024	BUY	$724.87 - $909.04 $72,487 - $90,904	100 Added 0.93%	10,850 $9.82 Million
Q1 2024 May 14, 2024	BUY	$592.2 - $792.28 $316,827 - $423,869	535 Added 5.24%	10,750 $8.36 Million
Q4 2023 Feb 06, 2024	BUY	$525.19 - $619.13 $164,909 - $194,406	314 Added 3.17%	10,215 $5.95 Million
Q3 2023 Oct 19, 2023	BUY	$434.7 - $599.3 $37,384 - $51,539	86 Added 0.88%	9,901 $5.32 Million
Q2 2023 Jul 31, 2023	BUY	$350.74 - $468.98 $14,731 - $19,697	42 Added 0.43%	9,815 $4.6 Million
Q1 2023 May 12, 2023	BUY	$310.63 - $364.82 $75,172 - $88,286	242 Added 2.54%	9,773 $3.36 Million
Q4 2022 Jan 23, 2023	SELL	$321.55 - $374.67 $81,030 - $94,416	-252 Reduced 2.58%	9,531 $0
Q3 2022 Nov 04, 2022	SELL	$296.48 - $337.87 $889 - $1,013	-3 Reduced 0.03%	9,783 $3.16 Million
Q2 2022 Aug 08, 2022	SELL	$278.73 - $327.27 $8,919 - $10,472	-32 Reduced 0.33%	9,786 $3.17 Million
Q1 2022 Apr 12, 2022	SELL	$234.69 - $291.66 $4,928 - $6,124	-21 Reduced 0.21%	9,818 $2.81 Million
Q4 2021 Jan 19, 2022	BUY	$224.85 - $279.04 $20,461 - $25,392	91 Added 0.93%	9,839 $2.72 Million
Q3 2021 Oct 25, 2021	SELL	$221.6 - $272.71 $22,603 - $27,816	-102 Reduced 1.04%	9,748 $2.25 Million
Q2 2021 Jul 19, 2021	SELL	$180.55 - $233.54 $51,817 - $67,025	-287 Reduced 2.83%	9,850 $2.26 Million
Q1 2021 May 05, 2021	SELL	$164.32 - $212.72 $29,577 - $38,289	-180 Reduced 1.74%	10,137 $1.89 Million
Q4 2020 Jan 28, 2021	SELL	$130.46 - $172.63 $22,439 - $29,692	-172 Reduced 1.64%	10,317 $1.74 Million
Q3 2020 Oct 28, 2020	SELL	$146.22 - $169.13 $31,875 - $36,870	-218 Reduced 2.04%	10,489 $1.55 Million
Q2 2020 Aug 10, 2020	SELL	$136.42 - $164.18 $36,151 - $43,507	-265 Reduced 2.42%	10,707 $1.76 Million
Q1 2020 Apr 28, 2020	SELL	$119.05 - $147.35 $11,905 - $14,735	-100 Reduced 0.9%	10,972 $1.52 Million
Q4 2019 Feb 10, 2020	SELL	$106.92 - $132.43 $6,094 - $7,548	-57 Reduced 0.51%	11,072 $1.45 Million
Q3 2019 Nov 07, 2019	SELL	$106.79 - $116.16 $52,327 - $56,918	-490 Reduced 4.22%	11,129 $1.24 Million
Q2 2019 Jul 22, 2019	BUY	$110.79 - $129.32 $11,189 - $13,061	101 Added 0.88%	11,619 $1.29 Million
Q1 2019 Apr 23, 2019	SELL	$111.31 - $131.02 $42,520 - $50,049	-382 Reduced 3.21%	11,518 $1.49 Million
Q4 2018 Jan 16, 2019	SELL	$105.9 - $118.64 $51,785 - $58,014	-489 Reduced 3.95%	11,900 $1.38 Million
Q3 2018 Nov 09, 2018	SELL	$85.86 - $107.31 $29,621 - $37,021	-345 Reduced 2.71%	12,389 $1.33 Million
Q2 2018 Aug 06, 2018	SELL	$75.7 - $86.88 $5,299 - $6,081	-70 Reduced 0.55%	12,734 $1.09 Million
Q1 2018 May 07, 2018	SELL	$74.21 - $87.6 $18,923 - $22,338	-255 Reduced 1.95%	12,804 $990,000
Q4 2017 Jan 26, 2018	BUY	$81.94 - $87.89 $1,229 - $1,318	15 Added 0.11%	13,059 $1.1 Million
Q3 2017 Oct 11, 2017	BUY	$77.07 - $85.54 $1.01 Million - $1.12 Million	13,044	13,044 $1.12 Million

Others Institutions Holding LLY

# of Institutions

4,011

Shares Held

751M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $730B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Blue Fin Capital, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Blue Fin Capital, Inc. with notifications on news.

Account

Blue Fin Capital, Inc. Eli Lilly & CO Transaction History